Bulthuis v. Rexall Corp.

777 F.2d 1353
CourtCourt of Appeals for the Ninth Circuit
DecidedDecember 3, 1985
DocketNos. 84-6090, 84-6145
StatusPublished
Cited by4 cases

This text of 777 F.2d 1353 (Bulthuis v. Rexall Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bulthuis v. Rexall Corp., 777 F.2d 1353 (9th Cir. 1985).

Opinions

PER CURIAM:

Defendant drug manufacturers were granted summary judgment on the ground there was no genuine issue that plaintiff’s mother did not take Diethylstilbestrol (DES) during her pregnancy with plaintiff. We reverse.

Plaintiff’s mother had three miscarriages before the birth of Elizabeth, her fourth child. Thirty years later plaintiff’s own pregnancy was terminated and surgery was performed because of cancer of the cervix. Plaintiff sued the seven pharmaceutical companies that manufactured and marketed DES during the time of her mother’s pregnancy with plaintiff under theories of strict liability, negligence, and breach of implied warranty, alleging that her injuries were caused by her mother’s ingestion of DES during her pregnancy to prevent a miscarriage. Defendants moved for summary judgment, arguing that the evidence obtained on discovery undisputedly showed that plaintiff’s mother had taken progesterone, not DES, during her pregnancy with plaintiff. The court granted summary judgment. Plaintiff appeals.

Defendants have the “burden of showing the absence of any genuine issue of fact.” Adickes v. S.H. Kress & Co., 398 U.S. 144, 153, 90 S.Ct. 1598, 1606, 26 L.Ed.2d 142 (1970). “[FJacts and inferences must be' viewed most favorably to” plaintiff. Aronsen v. Crown Zellerbach, 662 F.2d 584, 591 (9th Cir.1981). See also Dalke v. Upjohn Co., 555 F.2d 245, 248 (9th Cir.1977). If testimony conflicts so “that a result other than the district court’s conclusion is possible,” this court must reverse because “neither an appellate court nor a trial court are permitted to weigh the evidence, pass upon credibility, or speculate as to the ultimate findings of fact.” Id. To defeat summary judgment in the district court plaintiff was required to present evidence of specific facts showing that contradiction of the drug companies’ theory of non-liability is possible. See British Airways Bd. v. Boeing Co., 585 F.2d 946, 951 (9th Cir.1978). Our review is de novo. Jewel Companies, Inc. v. Pay Less Drug Stores Northwest, Inc., 741 F.2d 1555, 1559-60 (9th Cir.1984).

I.

Exclusion of Hearsay

In opposition to summary judgment, plaintiff presented her mother’s deposition testimony that in 1952 her attending doctor told her she was being given “stil[1355]*1355bestrol” — another name for DES. The district court declined to consider this testimony, holding it was hearsay and not admissible under Fed.R.Evid. 803(4) or 803(24). We agree. Rule 803(4) applies only to statements made by the patient to the doctor, not the reverse. Rule 803(24) requires guarantees of trustworthiness not present here — the statement of plaintiffs mother was plainly self-serving and no corroboration was available.

The court also declined to consider the affidavits of Dr. Sack and Dr. Townsend presented in opposition to the motion. Dr. Sack stated he had observed “ ‘changes’ in the tissue of [plaintiff’s] vaginal area which, in my opinion, were caused by her mother’s ingestion of the drug diethylstilbesterol [sic] (DES) while she was pregnant with” plaintiff. Dr. Townsend, who operated on plaintiff’s cancer, said in his affidavit his examination of plaintiff “showed changes that are commonly seen in DES exposed offspring and rarely seen in non-DES exposed individuals.” Dr. Townsend’s post-operative reports also reflected his opinion that plaintiff’s injuries were caused by DES.

The district court held the declarations of Doctors Townsend and Sack were insufficient to defeat summary judgment, stating:

Although expert testimony may defeat summary judgment, the declaration must put forward facts or a reasonable basis for the opinion. A declaration which simply presents an expert opinion without factual support is inadequate to defeat summary judgment.

It is not clear whether the district court ruled that a declaration of expert opinion was not admissible evidence without a recitation of the facts upon which the opinion was based, or that such a declaration in an affidavit, though admissible, was insufficient to create an issue of disputed fact barring summary judgment in the circumstances of this case. We think the ruling was wrong on either ground.

By the express terms of Fed.R.Evid. 705, “[t]he expert may testify in terms of opinion or inference and give his reasons therefore without prior disclosure of the underlying facts or data unless the court requires otherwise.” The court did not “require otherwise” in this case; it simply accorded the declarations of opinion no weight and granted summary judgment against plaintiff.

The court apparently rejected Dr. Sack’s declaration solely on the ground that Dr. Sack’s affidavit did not include the facts on which his opinion was based, remarking “Dr. Sack’s declaration ... does not state facts setting forth the basis for reaching the opinion that plaintiff’s condition was caused by DES.” But Dr. Sack said he based his opinion upon “ ‘changes’ in the tissue of [plaintiff's] vaginal area.” In view of the presumption established by Rule 705 that supporting facts need not be stated unless requested, it would be unfair to grant summary judgment against plaintiff without affording an opportunity to supply them. If the judge in his discretion decided more detail was desirable, plaintiff should have been permitted to supply it.

The district court discounted Dr. Townsend’s declaration on a different ground, stating, “[Although he states that plaintiff’s condition is commonly associated with cases involving DES, he offers neither expert testimony that plaintiff was exposed to DES nor facts to support such an opinion.” But Dr. Townsend stated that the changes he observed in plaintiff’s tissue were “commonly seen in DES exposed offspring and rarely seen in non-DES exposed individuals.” This was a statement of fact, and it is a reasonable inference from this fact that plaintiff’s mother had taken DES during her pregnancy with plaintiff. As the party against whom summary judgment was sought, plaintiff was entitled to have such inferences drawn in her favor.

The district court relied on United States v. Various Slot Machines on Guam, 658 F.2d 697, 699-701 (9th Cir.1981), and Thornhill Publishing Co. v. GTE Corp., 594 F.2d 730, 738 (9th Cir.1979). But neither of those cases support the exclusion of the expert opinion evidence in this case.

[1356]*1356Thornhill is farthest from the mark. It does not involve expert testimony. The court held inadequate to bar summary judgment the affidavit of a businessman which stated that an alleged violation of the Sherman Act affected interstate commerce, but did not provide specific facts supporting this conclusion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Amy Shields v. Eli Lilly and Company
895 F.2d 1463 (D.C. Circuit, 1990)
Ackerman v. Schwartz
733 F. Supp. 1231 (N.D. Indiana, 1989)
Shields v. Eli Lilly & Co.
704 F. Supp. 260 (District of Columbia, 1988)
Bulthuis v. Rexall Corporation
777 F.2d 1353 (Ninth Circuit, 1985)

Cite This Page — Counsel Stack

Bluebook (online)
777 F.2d 1353, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bulthuis-v-rexall-corp-ca9-1985.